Back to today’s briefing

Story perspectives

New Study Links Genetic Variants to Kidney Disease Risk

2/13/2025

40 6

Summary

Story summary

Genetic variants APOL1 G1 and G2 have been linked to a heightened risk of kidney disease among black Africans, according to a groundbreaking study by the Kidney Disease Research Network. Conducted in Nigeria and Ghana, this research paves the way for enhanced screening and treatment strategies, including the promising new drug, Inaxaplin, offering hope for better health outcomes.

1 of 1

Story summary

Genetic variants APOL1 G1 and G2 have been linked to a heightened risk of kidney disease among black Africans, according to a groundbreaking study by the Kidney Disease Research Network. Conducted in Nigeria and Ghana, this research paves the way for enhanced screening and treatment strategies, including the promising new drug, Inaxaplin, offering hope for better health outcomes.